EcoDrugPlus

Ensembl ID : ENSATEG00000028478
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSATEG00000028509
Gene Symbol: -
1 Cross references
212 Possible Orthologues:

Ensembl ID : ENSATEG00000009006
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSATEG00000028660
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSATEG00000003232
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSATEG00000009108
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSATEG00000000381
Gene Symbol: -
Cross references: -
470 Possible Orthologues:

Ensembl ID : ENSATEG00000005009
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSATEG00000023236
Gene Symbol: -
Cross references: -
314 Possible Orthologues:

Ensembl ID : ENSATEG00000008341
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSATEG00000006013
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSATEG00000011751
Gene Symbol: -
Cross references: -
254 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).